TotalMarketCap

Processa Pharmaceuticals

PCSANasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$5.261 M

$1.88 -3.59%

Close of 6 Nov 2026

As of 6 Nov 2026, Processa Pharmaceuticals (PCSA) has a market capitalization of $5.26M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$13.6M

Loss-making

Shares outstanding

2,793,386

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #447Jaguar HealthJAGX$5.35M
  2. #448PulmatrixPULM$5.31M
  3. #449Processa PharmaceuticalsPCSA$5.26M
  4. #450ScientureSCNX$5.18M
  5. #451GelteqGELS$4.88M

What if Processa Pharmaceuticals were worth as much as…

Open the what-if tool →

Gold $28.2T

$10,090,937

Per share 5,367,520× higher

Bitcoin $1.53T

$546,003.04

Per share 290,427× higher

Apple $5.02T

$1,792,477

Per share 953,445× higher

Or at a round number

$10.0M$20.0M$50.0M$100.0M

Where these numbers come from

Share counts and financials for Processa Pharmaceuticals are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.